¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fatty cirrhosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • atrophic cirrhosis
    À§Ãà°£°æÈ­(Áõ)
  • alcoholic cirrhosis
    ¾ËÄڿð£°æÈ­(Áõ)
  • biliary cirrhosis
    ¾µ°³°ü°£°æÈ­(Áõ), ´ã°ü°£°æÈ­(Áõ)
  • cirrhosis
    °æÈ­(Áõ)
  • congestive cirrhosis
    ¿ïÇ÷°æÈ­(Áõ)
  • cardiac cirrhosis
    ½ÉÀ强°£°æÈ­(Áõ)
  • hepatic cirrhosis
    °£°æÈ­(Áõ)
  • juvenile cirrhosis
    ¼Ò¾Æ°£°æÈ­Áõ
  • liver cirrhosis
    °£°æÈ­Áõ
  • Laennec cirrhosis
    ¶ó¿¡³Ø°£°æÈ­(Áõ)
  • multilobular cirrhosis
    ´Ù¿±°£°æÈ­Áõ
  • nutritional cirrhosis
    ¿µ¾ç°£°æÈ­(Áõ)
  • obstructive biliary cirrhosis
    Æó¼â¾µ°³°ü°£°æÈ­(Áõ)
  • obstructive liver cirrhosis
    ÆÐ¼â°£°æÈ­(Áõ)
  • pigmentary cirrhosis
    »ö¼Ò°£°æÈ­(Áõ)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cirrhosis
    °æÈ­(Áõ)
  • cardiac cirrhosis
    ½ÉÀå°£°æÈ­(Áõ)
  • congestive cirrhosis
    ¿ïÇ÷°æÈ­(Áõ)
  • hepatic cirrhosis
    °£°æº¯(Áõ)
  • juvenile cirrhosis
    ¿¬¼ÒÀÚ°£°æÈ­(Áõ)
  • multilobular cirrhosis
    ´Ù¿±°£°æÈ­(Áõ)
  • nutritional cirrhosis
    ¿µ¾ç°£°æÈ­(Áõ)
  • obstructive biliary cirrhosis
    Æó¼â¾µ°³°ü°æÈ­(Áõ)
  • obstructive liver cirrhosis
    ÆÐ¼â°£°æÈ­(Áõ)
  • pigmentary cirrhosis
    »ö¼Ò°£°æÈ­(Áõ)
  • pipe stem cirrhosis
    ÆÄÀÌÇÁ°ü°£°æÈ­(Áõ)
  • posthepatitic cirrhosis
    °£¿°Èİ£°æÈ­(Áõ)
  • postnecrotic cirrhosis
    ±«»çÈİ£°æÈ­(Áõ)
  • primary biliary cirrhosis
    ¿ø¹ß¾µ°³°ü°£°æÈ­(Áõ)
  • secondary biliary cirrhosis
    ¼Ó¹ß¾µ°³°ü°£°æÈ­(Áõ)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pigmentary cirrhosis
    »ö¼Ò¼º °£°æº¯(Áõ)(ßäáÈàõ ÊÜÌãܨ(ñø))
  • pipestem cirrhosis
    ÆÄÀÌÇÁ°ü°£°æº¯Áõ(¡­ÊÜÌãܨñø).
  • portal (liver) cirrhosis ³ª c. portalis
    ¹®¸Æ¼º °£°æº¯(Áõ)( Ú¦ØæàõÊÜÌãܨñø).
  • portal (liver) cirrhosis ³ª c. portalis
    ¹®¸Æ¼º °£°æº¯(Áõ)(Ú¦Øæàõ ÊÜÌãܨ(ñø))
  • posthepatitic cirrhosis
    °£¿°Èļº °£°æº¯Áõ(ÊÜæúý­àõÊÜÌãܨñø).
  • posthepatitic cirrhosis
    °£¿°Èļº °£°æº¯Áõ(ÊÜæúý­àõ ÊÜÌãܨñø)
  • postnecrotic cirrhosis
    ±«»çÈÄ(¼º) °£°æº¯(Áõ)(ÎÕÞÝý­(àõ) ÊÜÌãܨ(ñø))
  • primary biliary cirrhosis
    ¿ø¹ß¼º ´ãÁó¼º °£°æº¯(Áõ)
  • primary biliary cirrhosis
    ¿ø¹ß(¼º) ´ãÁó¼º °£°æº¯(Áõ)(ê«Û¡(àõ) ÓÅñðàõ ÊÜÌãܨ(ñø))
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fatty exudate
    Áö¹æ»ïÃâ¹°, °æ¼º»ïÃâ¹°
  • fatty food intolerance
    Áö¹æ½ÄºÒ³»¼º(¡­ãÝÝÕÒ±àõ).
  • fatty ingrowth
    Áö¹æ ħÀ±(¡­öÙëÈ)
  • fatty liver
    Áö¹æ°£(ò·Û¸ÊÜ)
  • fatty liver
    Áö¹æ°£(ò·Û¸ÊÜ).
  • fatty liver
    Áö¹æ°£(ò·Û¸ÊÜ)
  • fatty oil
    Áö¹æÀ¯(̤ËÑËô).
  • fatty stool
    Áö¹æº¯(ò·Û¸øµ).
  • fatty streak
    Áö¹æ ¼±Á¶
  • free fatty acid
    À¯¸®Áö¹æ»ê.
  • free fatty acid.
    À¯¸®Áö¹æ»ê
  • non-esterified fatty acid
    ºñ¿¡½ºÅ׸£È­Áö¹æ»ê
  • nonesterified fatty acid
    ºñ¿¡½ºÅ׸£È­Áö¹æ»ê(Þª~ûùò·Û¸ß«).
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê(øöñÞò·Û¸ß«).
  • omega-3 fatty acid
    ¿À¸Þ°¡-3 Áö¹æ»ê(¡­ò·Û¸ß«)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fatty liver
    Áö¹æ°£(ò·Û¸ÊÜ)
  • free fatty acids
    À¯¸® Áö¹æ»ê(ë´×îò·Û¸ß«)
  • iso fatty acid
    ¾ÆÀ̼ÒÁö¹æ»ê(ò·Û¸ß«)
  • long-chain fatty acid thiokinase
    ±ä»ç½½Áö¹æ»ê(ò·Û¸ß«) Ƽ¿ÀÄ«À̳×À̽º
  • medium-chain fatty acid thiokinase
    Áß(ñé)»ç½½ Áö¹æ»ê(ò·Û¸ß«) Ä¡¿ÀÄ«À̳×À̽º
  • monoenoic fatty acid
    ÀÏ(ìé)¿£ Áö¹æ»ê(ò·Û¸ß«)
  • odd-numbered fatty acid
    Ȧ¼ö Áö¹æ»ê(ò·Û¸ß«)
  • polyenoic fatty acid
    Æú¸®¿¡³ëÀÎ Áö¹æ»ê(ò·Û¸ß«)
  • polyunsaturated fatty acid
    ´ÙºÒÆ÷È­ Áö¹æ»ê(ÒýÝÕøéûúò·Û¸ß«)
  • saturated fatty acid
    Æ÷È­ Áö¹æ»ê(øéûùò·Û¸ß«)
  • unsaturated fatty acid
    ºÒÆ÷È­(ÝÕøéûú) Áö¹æ»ê(ò·Û¸ß«)
  • very long-chain fatty acids
    ¸Å¿ì ±ä »ç½½ Áö¹æ»ê(ò·Û¸ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PBC Primary Biliary Cirrhosis
AC abdominal circumference; abdominal compression; absorption coefficient; abuse case; acetate; acetylc...
CAC/CIC chronic active/inactive cirrhosis
CL capillary lumen; cardiolipin; cell line; centralis lateralis; chemiluminescence; chest and left arm ...
FRFC functional renal failure of cirrhosis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ALC alcoholic liver cirrhosis
FA 2-fatty acid
PUFA Polyunsaturated fatty acid
AFLP Acute fatty liver of pregnancy
CFA Cellular fatty acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fatty metamorphosis
    Áö¹æ º¯È­, Áö¹æ º¯¼º, Áö¹æ º¯
  • fatty streak
    Áö¹æ¼º ¶ì, Áö¹æ ¼±Á¶
    µ¿¸Æ³»¿¡ ÁÖ·Î ÄÝ·¹½ºÅ×·Ñ¿¡ ÀÇÇÏ¿© ±¸¼ºµÈ ÀÛÀº ÆíÆòÇÑ È²È¸»ö ºÎÀ§. ¾Æ¸¶µµ Á×»ó µ¿¸Æ °æÈ­ÁõÀÇ ÃʱâÀÏ °ÍÀÌ´Ù. Á÷°æÀÌ 1mm ÀÌÇÏÀÎ ´Ù¹ß¼º Ȳ»ö Á¡À¸·Î ½ÃÀÛÇÏ¸ç ÆøÀÌ 1-2mmÀÌ°í ±æÀ̰¡ 1cm Á¤µµÀÇ ¼±Á¶°¡ µÈ´Ù. Áö¹æ ¼±Á¶´Â ÁöÁú·Î ±¸¼ºµÈ Æ÷¸» ¼¼Æ÷·Î ±¸¼ºµÇ¾î ÀÖ´Ù. T-¼¼Æ÷, ¼¼Æ÷ÀÇ ÁöÁúÀÌ Á×Á¾¼º ÆÇº¸´Ù Àû°Ô ÀÖ°í, ÇÁ·ÎÅ׿À±Û¸®Ä­, ÄݶóÁ¨ ¹× ź·Â ¼¶À¯µµ ´Ù¾çÇÑ Á¤µµ·Î Á¸ÀçÇÑ´Ù. Áö¿ª, ÀÎÁ¾, ¼ºº° ȤÀº ȯ°æ¿¡ °ü°è¾øÀÌ 1³â ÀÌ»óµÈ ¼Ò¾ÆÀÇ ´ëµ¿¸Æ¿¡ ³ªÅ¸³ª°í °ü»ó µ¿¸Æ Áö¹æ ¼±Á¶´Â »çÃá±â¿¡ ½ÃÀ۵Ǹç, Á×Á¾¼º ÆÇÀÌ ¹ß»ýµÇ´Â ÇØºÎÇÐÀûÀÎ À§Ä¡¿Í ÀÏÄ¡ÇÑ´Ù.
  • free fatty acid
    À¯¸® Áö¹æ»ê
  • no fatty coating
    ºñ Áö¹æ¼º ÇǺ¹
  • polyunsaturate fatty acid
    ´ÙºÒÆ÷È­ Áö¹æ»ê
  • saturated fatty acid
    Æ÷È­ Áö¹æ»ê
  • serum free fatty acid
    Ç÷û À¯¸® Áö¹æ»ê Á¤·®
    Á¤»óÄ¡´Â Á¶±â °øº¹ ½Ã 200-600¥ìEq/l·Î »ý¸®Àû º¯µ¿ÀÌ Å©´Ù.
  • subcutaneous fatty tissue
    ÇÇÇÏ Áö¹æ Á¶Á÷
  • total fatty acids
    ÃÑ Áö¹æ»ê
  • unesterified fatty acid
    ºñ¿¡½ºÅ׸£È­ Áö¹æ»ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
cryptogenic cirrhosis Cirrhosis of unknown aetiology, with no history of alcoholism or previous acute hepatitis.
(05 Mar 2000)
postnecrotic cirrhosis Post-necrotic cirrhosis, cirrhosis characterised by necrosis involving whole hepatic lobules, with collapse of the reticular framework to form large scars; regeneration nodules are also large; may follow viral or toxic necrosis, or develop as a result of ischemic necrosis.
Synonym: necrotic cirrhosis.
(05 Mar 2000)
Hanot's cirrhosis <gastroenterology> A rare form of liver disease which results in the irreversible destruction of the liver and bile ducts. The cause is unknown, but is thought to be an autoimmune mechanism.
(06 Mar 1998)
primary biliary cirrhosis <gastroenterology> A rare form of liver disease which results in the irreversible destruction of the liver and bile ducts. The cause is unknown, but is thought to be an autoimmune mechanism.
(06 Mar 1998)
pulmonary cirrhosis Fibrosis of the lungs; usually interstitial pulmonary fibrosis.
(05 Mar 2000)
stasis cirrhosis An extensive fibrotic reaction within the liver as a result of chronic constrictive pericarditis or prolonged congestive heart failure; true cirrhosis with fibrous bridging of lobules is unusual.
Synonym: cardiac liver, congestive cirrhosis, pseudocirrhosis, stasis cirrhosis.
(05 Mar 2000)
necrotic cirrhosis Post-necrotic cirrhosis, cirrhosis characterised by necrosis involving whole hepatic lobules, with collapse of the reticular framework to form large scars; regeneration nodules are also large; may follow viral or toxic necrosis, or develop as a result of ischemic necrosis.
Synonym: necrotic cirrhosis.
(05 Mar 2000)
nutritional cirrhosis Cirrhosis occurring in persons or animals with general or specific dietary deficiencies; methionine and cystine deficiency may produce changes of cirrhosis in animals, but it is uncertain whether malnutrition in humans leads to cirrhosis or only to reversible fatty infiltration of the liver.
(05 Mar 2000)
syphilitic cirrhosis Cirrhosis of the liver occurring as a result of tertiary or congenital syphilis.
(05 Mar 2000)
toxic cirrhosis Cirrhosis of the liver resulting from chronic poisoning, as by lead or carbon tetrachloride.
(05 Mar 2000)
juvenile cirrhosis <pathology> This is a form of continuing liver inflammation that results in liver cell death. Causes include viral infection (hepatitis D, hepatitis B, hepatitis C), autoimmune disease, drug ingestion or metabolic causes. Chronic active hepatitis will lead to hepatic failure and death in a small percentage of these patients.
(27 Sep 1997)
Laennec's cirrhosis Alcoholic cirrhosis is a condition of irreversible liver disease due to the chronic inflammatory and toxic effects of ethanol on the liver. In cirrhosis, the liver cells are replaced by fibrous scar tissue. Fibrosis leads to the development of portal hypertension. The development of cirrhosis is directly related to the duration and quantity of alcohol consumption. The manifestations of cirrhosis are related to the liver's inability to not adequately remove waste products from the bloodstream and the effects of portal hypertension.
(27 Sep 1997)
liver cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
(12 Dec 1998)
liver cirrhosis, alcoholic Liver cirrhosis in alcoholics.
(12 Dec 1998)
liver cirrhosis, biliary Liver cirrhosis in which there is interference with intrahepatic bile flow. It includes primary biliary cirrhosis, an intrahepatic disturbance of bile secretion affecting predominantly middle-aged women and with segmental destruction and, later, absence of septal bile ducts (cirrhosis is the end stage); and secondary biliary cirrhosis, which is produced by prolonged mechanical obstruction of large intrahepatic or extrahepatic bile ducts.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á